MacroGenics
MGNX
#8652
Rank
HK$1.84 B
Marketcap
HK$29.01
Share price
-7.73%
Change (1 day)
121.34%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of March 2026 : HK$1.20 Billion

According to MacroGenics's latest financial reports the company has HK$1.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$1.47 B-5.62%
2024-12-31HK$1.56 B-12.77%
2023-12-31HK$1.79 B48.83%
2022-12-31HK$1.20 B-36.52%
2021-12-31HK$1.89 B-10.09%
2020-12-31HK$2.11 B25.73%
2019-12-31HK$1.68 B-7.85%
2018-12-31HK$1.82 B-23.51%
2017-12-31HK$2.38 B10.98%
2016-12-31HK$2.14 B-18.26%
2015-12-31HK$2.62 B114.99%
2014-12-31HK$1.22 B35.33%
2013-12-31HK$0.90 B144.07%
2012-12-31HK$0.37 B-13.71%
2011-12-31HK$0.42 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$102.53 B 8,377.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$41.42 B 3,324.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$94.39 B 7,705.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$59.93 B 4,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$44.71 B 3,597.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.22 B 6,698.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$3.48 B 188.50%๐Ÿ‡บ๐Ÿ‡ธ USA